Literature DB >> 1105513

Some properties of beclomethasone dipropionate and related steroids in man.

D M Harris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1105513

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  19 in total

1.  Bone turnover during high dose inhaled corticosteroid treatment.

Authors:  N J Ali; S Capewell; M J Ward
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

2.  The place of beclomethasone dipropionate aerosol in the treatment of asthma.

Authors:  I Gregg
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 3.  Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.

Authors:  Pilar López-Serrano; Elsa de la Fuente Briongos; Elisa Carrera Alonso; Jose Lázaro Pérez-Calle; Conrado Fernández Rodríguez
Journal:  World J Hepatol       Date:  2015-03-27

Review 4.  Pediatric ulcerative colitis: a practical guide to management.

Authors:  Brian P Regan; Athos Bousvaros
Journal:  Paediatr Drugs       Date:  2014-06       Impact factor: 3.022

5.  Combined oral and nasal beclomethasone diproprionate in children with atopic eczema: a randomised controlled trial.

Authors:  R J Heddle; J F Soothill; C J Bulpitt; D J Atherton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-15

6.  Beclomethasone dipropionate inhaler: a review of its pharmacology, therapeutic value and adverse effects. I: Asthma.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 7.  Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

8.  Oral beclomethasone dipropionate as an alternative to systemic steroids in mild to moderate ulcerative colitis not responding to aminosalicylates.

Authors:  Claudio Papi; Annalisa Aratari; Alessandra Moretti; Manuela Mangone; Giovanna Margagnoni; Maurizio Koch; Lucio Capurso
Journal:  Dig Dis Sci       Date:  2009-09-05       Impact factor: 3.199

9.  The influence of a new corticosteroid, budesonide, on anaphylactic bronchoconstriction and SRS-A release in the guinea pig.

Authors:  K Forsberg; L Sörenby
Journal:  Agents Actions       Date:  1981-07

Review 10.  Pharmacologic treatment of rhinitis.

Authors:  F E Simons; K J Simons
Journal:  Clin Rev Allergy       Date:  1984-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.